Avasimibe
| Price | $1 |
| Package | 1g |
| Min. Order: | 200KG |
| Supply Ability: | 2tons |
| Update Time: | 2019-12-20 |
Product Details
| Product Name: Avasimibe | CAS No.: 166518-60-1 |
| Min. Order: 200KG | Purity: 99% |
| Supply Ability: 2tons | Release date: 2019/12/20 |
Mary
▼
▲
Product Name:
Avasimibe
Synonyms:
Ava Maibu;avasimibe;n-(2,6-dipropan-2-ylphenoxy)sulfonyl-2-(2,4,6-tripropan-2-ylphenyl)acetamide;N-[(2,6-DIISOPROPYLPHENOXY)SULFONYL]-2-(2,4,6-TRIISOPROPYLPHENYL)ACETAMIDE;((2,4,6-TRIS(1-METHYLETHYL)PHENYL)ACETYL)SULFAMICACID2,6-BIS(1-METHYLETHYL)PHENYLESTER;Avasimibe(CI-1011);1-[(2,6-DIISOPROPYLPHENOXYSULFONYL)AMINO]-2-(2,4,6-TRIISOPROPYLPHENYL)ETHANONE;CI-1011
CAS:
166518-60-1
MF:
C29H43NO4S
MW:
501.72102
EINECS:
1592732-453-0
Product Categories:
Inhibitors
Mol File:
166518-60-1.mol
▼
▲
Avasimibe Chemical Properties
▼
▲
Melting point
178-180° (Lee); mp 169.5-170.4° (Dozeman)
density
1.072±0.06 g/cm3(Predicted)
storage temp.
room temp
solubility
DMSO: ≥40mg/mL
form
powder
pka
1.97±0.70(Predicted)
color
white to tan
InChIKey
PTQXTEKSNBVPQJ-UHFFFAOYSA-N
▼
▲
Safety Information
▼
▲
WGK Germany
3
▼
▲
MSDS Information
▼
▲
Avasimibe Usage And Synthesis
▼
▲
Uses
Avasimibe is a selective inhibitor of Cholesterol Acyltransferase 1 and CYP2C9. Avasimibe is known to induce apoptosis of glioma cell lines as a model of glioblastoma.
▼
▲
Avasimibe Preparation Products And Raw materials
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates：
Pharmaceutical intermediates;
OLED intermediates;
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $43.00/10mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
| $1670.00/25mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 |
China- Since: 2014-12-17
- Address: Room 702, Floor 7, Building 10, National University Science Park, High-Tech Zone, Zhengzhou City, H
INQUIRY